Improving erythropoiesis: a compelling case for iron chelation in myelofibrosis.

Authors	Vinod Pullarkat
Journal	European journal of haematology (Eur J Haematol) Vol. 96 Issue 6 Pg. 549-50 (Jun 2016) ISSN: 1600-0609 [Electronic] England
PMID	26572646 (Publication Type: Editorial)
Chemical References	Iron Chelating Agents
Topics	Erythrocyte Transfusion (adverse effects) Erythropoiesis (drug effects) Humans Iron Chelating Agents (pharmacology, therapeutic use) Iron Overload (drug therapy, etiology) Primary Myelofibrosis (complications, physiopathology, therapy) Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!